NO149311C - Analogifremgangsmaate til fremstilling av terapeutisk aktive propanolindolderivater - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive propanolindolderivater

Info

Publication number
NO149311C
NO149311C NO782407A NO782407A NO149311C NO 149311 C NO149311 C NO 149311C NO 782407 A NO782407 A NO 782407A NO 782407 A NO782407 A NO 782407A NO 149311 C NO149311 C NO 149311C
Authority
NO
Norway
Prior art keywords
propanol
industries
preparation
therapeutically active
analogy procedure
Prior art date
Application number
NO782407A
Other languages
English (en)
Norwegian (no)
Other versions
NO782407L (no
NO149311B (no
Inventor
William E Kreighbaum
William T Comer
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NO782407L publication Critical patent/NO782407L/no
Publication of NO149311B publication Critical patent/NO149311B/no
Publication of NO149311C publication Critical patent/NO149311C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
NO782407A 1977-07-13 1978-07-11 Analogifremgangsmaate til fremstilling av terapeutisk aktive propanolindolderivater NO149311C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81513877A 1977-07-13 1977-07-13

Publications (3)

Publication Number Publication Date
NO782407L NO782407L (no) 1979-01-16
NO149311B NO149311B (no) 1983-12-19
NO149311C true NO149311C (no) 1984-03-28

Family

ID=25216976

Family Applications (1)

Application Number Title Priority Date Filing Date
NO782407A NO149311C (no) 1977-07-13 1978-07-11 Analogifremgangsmaate til fremstilling av terapeutisk aktive propanolindolderivater

Country Status (30)

Country Link
JP (1) JPS5419972A (de)
AR (1) AR225274A1 (de)
AT (1) AT364821B (de)
AU (1) AU525064B2 (de)
BE (1) BE868943A (de)
CA (1) CA1116598A (de)
CH (1) CH642066A5 (de)
CY (1) CY1274A (de)
DE (1) DE2830884A1 (de)
DK (1) DK156568C (de)
ES (1) ES471674A1 (de)
FI (1) FI69835C (de)
FR (1) FR2397404A1 (de)
GB (1) GB2001633B (de)
GR (1) GR74488B (de)
HK (1) HK1385A (de)
HU (1) HU178992B (de)
IE (1) IE47122B1 (de)
IL (1) IL55115A (de)
IT (1) IT1105091B (de)
KE (1) KE3485A (de)
LU (1) LU79966A1 (de)
MY (1) MY8500946A (de)
NL (1) NL189946C (de)
NO (1) NO149311C (de)
NZ (1) NZ187763A (de)
SE (1) SE429339B (de)
SG (1) SG82584G (de)
YU (1) YU40528B (de)
ZA (1) ZA783744B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2463765A1 (fr) * 1979-08-17 1981-02-27 Clin Midy Nouveaux derives de l'indole actifs sur le systeme cardiovasculaire
US4321398A (en) * 1981-05-07 1982-03-23 Mead Johnson & Company Thienyl and benzothienyl-tertiary butylaminophenoxypropanols
DE3119796A1 (de) * 1981-05-19 1982-12-23 Hoechst Ag, 6000 Frankfurt Substituierte tryptaminderivate von thienyloxpropanolaminen, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen sowie ihre verwendung
FR2523964B1 (fr) * 1982-03-23 1985-09-27 Sanofi Sa Nouveaux derives de la tryptamine actifs notamment sur le systeme cardiovasculaire et procede pour leur preparation
NZ208337A (en) * 1983-06-10 1988-10-28 Bristol Myers Co 2-(2-hydroxy-3-((2-(ar-hydroxy-1h-aminopropoxy-yl)ethyl benzonitriles and pharmaceutical compositions
FR2601008B1 (fr) * 1986-07-03 1990-03-30 Sanofi Sa Procede de synthese stereospecifique de derives de l'indole
CA2421594A1 (en) 2000-11-10 2002-05-16 John Arnold Werner 3-substituted oxindole beta 3 agonists
DE60211199T2 (de) 2001-08-14 2007-02-01 Eli Lilly And Co., Indianapolis 3-substituierte oxindol-beta-3-agonisten
ES2272749T3 (es) * 2001-08-14 2007-05-01 Eli Lilly And Company Derivados de indol como agonistas beta-3 adrenergicos para el tratamiento de diabetes tipo 2.
JP2005518357A (ja) 2001-11-20 2005-06-23 イーライ・リリー・アンド・カンパニー ベータ3アドレナリンアゴニスト
ATE297925T1 (de) 2001-11-20 2005-07-15 Lilly Co Eli 3-substituierte oxindol beta 3 agonisten
US7009060B2 (en) 2002-01-11 2006-03-07 Eli Lilly And Company 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists
CA2960254A1 (en) 2008-08-01 2010-02-04 Arca Biopharma, Inc. Methods and compositions involving (s)-bucindolol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1532210A (fr) * 1963-06-21 1968-07-12 Ici Ltd Composés hétérocycliques et leur procédé de préparation
CH495983A (de) * 1968-02-09 1970-09-15 Sandoz Ag Verfahren zur Herstellung von linksdrehendem 4-(2-Hydroxy-3-isopropylaminopropoxy)indol
US3371098A (en) * 1966-11-29 1968-02-27 Philips Corp 5- and 6-methoxy-3-(phenoxyethyl-aminoethyl)-indoles
US3946009A (en) * 1972-05-05 1976-03-23 Merck Sharp & Dohme (I.A.) Corporation 2-(3-Substituted amino-2-hydroxypropoxy)-3-substituted pyrazines

Also Published As

Publication number Publication date
DK156568B (da) 1989-09-11
ZA783744B (en) 1979-07-25
FR2397404A1 (fr) 1979-02-09
GB2001633A (en) 1979-02-07
GR74488B (de) 1984-06-28
NO782407L (no) 1979-01-16
FR2397404B1 (de) 1982-06-11
NL189946C (nl) 1993-09-16
CY1274A (en) 1985-03-08
SE7807700L (sv) 1979-01-14
IT1105091B (it) 1985-10-28
YU161178A (en) 1983-02-28
YU40528B (en) 1986-02-28
MY8500946A (en) 1985-12-31
ATA508978A (de) 1981-04-15
IE781400L (en) 1979-01-13
LU79966A1 (fr) 1979-04-09
CA1116598A (en) 1982-01-19
IT7850228A0 (it) 1978-07-10
AT364821B (de) 1981-11-25
NL189946B (nl) 1993-04-16
SG82584G (en) 1985-09-13
SE429339B (sv) 1983-08-29
BE868943A (fr) 1979-01-12
ES471674A1 (es) 1979-10-01
DK313878A (da) 1979-01-14
JPS5419972A (en) 1979-02-15
GB2001633B (en) 1982-03-24
AU3770478A (en) 1980-01-10
IL55115A0 (en) 1978-09-29
AR225274A1 (es) 1982-03-15
DE2830884C2 (de) 1990-01-11
CH642066A5 (de) 1984-03-30
NL7807564A (nl) 1979-01-16
DE2830884A1 (de) 1979-02-01
FI69835B (fi) 1985-12-31
HK1385A (en) 1985-01-11
JPS6340784B2 (de) 1988-08-12
FI782205A (fi) 1979-01-14
KE3485A (en) 1985-01-25
AU525064B2 (en) 1982-10-21
IL55115A (en) 1981-09-13
NO149311B (no) 1983-12-19
IE47122B1 (en) 1983-12-28
DK156568C (da) 1990-02-05
FI69835C (fi) 1986-05-26
NZ187763A (en) 1984-07-31
HU178992B (en) 1982-07-28

Similar Documents

Publication Publication Date Title
NO147025C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme pyridinyl-2(1h)-pyridinoner
NO145691C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme decapeptidamider
NO160211C (no) Analogifremgangsmaate til fremstilling av nye terapeutisk virksomme cefemderivater.
NO147450C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater
NO145379C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamider.
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
NO145307C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk virksomme nucleosider
NO147953C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglukosider
NO143796C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme piperazinyliminorifamyciner
NO146095C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinazolin-derivater
NO145762C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracyklinglykosidiske forbindelser
NO149311C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive propanolindolderivater
NO150081C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme derivater av perhydro-aza-heterocykler
NO149313C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO146022C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme benzofenonderivater
NO149037C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO146571C (no) Analogifremgangsmaate ved fremstilling av anti-inflammatorisk aktive imidazoler
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
NO150279C (no) Analogifremgangsmaate til fremstilling av nye terapeutisk virksomme benzopyranderivater
NO144604C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme histidinderivater
NO145163C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider
NO151008C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroforbindelser
NO142907C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme fenylalkylaminer
DK295378A (da) Fremgangsmaade til fremstilling af terapeutisk virksomme diarylalkylaminer
NO144741C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiopyrano-pyrazoler